By Thomas Dobrow Zimmer Biomet Holdings (NYSE:ZBH) has earned a consensus rating of “Buy” from the seventeen research firms that are presently covering the stock, MarketBeat Ratings reports. Five research analysts have rated the stock with a hold rating and eleven have assigned